David S. Kabakoff serves as Executive at Trius Therapeutics Inc, where they oversee executive responsibilities. Since joining the company, David S. Kabakoff has executed 62 insider transactions totaling $65.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 30, 2013 involved selling 10,002 shares valued at $148.2K.
David S. Kabakoff currently holds 503,577 shares of Trius Therapeutics Inc (TSRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David S. Kabakoff has been a net seller of TSRX stock. They have purchased $1.1M and sold $64.8M worth of shares.
David S. Kabakoff's most recent insider trade was on Aug 30, 2013, when they sold 10,002 shares at $14.82 per share.
Get notified when new Form 4 filings are submitted
| $10.10 |
| Discretionary |
| Jun 2, 2011 | ITMN | $0 | Gift | 15,000 | $N/A | Discretionary |
| Jun 2, 2011 | ITMN | $72.8K | Sale | 2,000 | $36.41 | Discretionary |
| Jan 28, 2011 | ITMN | $136.0K | Option Exercise | 12,000 | $11.33 | Discretionary |
| Jan 28, 2011 | ITMN | $152.4K | Option Exercise | 10,002 | $15.24 | Discretionary |
| Jan 28, 2011 | ITMN | $457.2K | Option Exercise | 30,000 | $15.24 | Discretionary |
| Oct 8, 2010 | TSRX | $23.9K | Option Exercise | 18,531 | $1.29 | Discretionary |
| Oct 8, 2010 | TSRX | $14.3K | Option Exercise | 11,120 | $1.29 | Discretionary |
| Aug 6, 2010 | TSRX | $0 | Conversion | 5,285 | $N/A | Discretionary |
| Aug 6, 2010 | TSRX | $150.0K | Purchase | 30,000 | $5.00 | Discretionary |
| Aug 6, 2010 | TSRX | $0 | Conversion | 4,570 | $N/A | Discretionary |